"Old drugs" for the treatment of rheumatoid arthritis: Will the cholinergic anti-inflammatory pathway and anti-nociceptive pathway work?

Inflammation Research

Volumn 59, Issue 12, 2010, Pages 1005-1007

  Pan, Xiaohua ^c   Yu, Xiaowei ^d   Qin, Ling ^a,b   Zhang, Peng ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c JINAN UNIVERSITY   (China)

^d Second Affiliated Hospital   (China)

Author keywords

Cholinergic anti inflammatory pathway; Cholinergic anti nociceptive pathway; Old drugs; Rheumatoid arthritis

Indexed keywords

3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE; ACETYLSALICYLIC ACID; BUNGAROTOXIN RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; JANUS KINASE 2; NONSTEROID ANTIINFLAMMATORY AGENT; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANTICHOLINERGIC EFFECT; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; B LYMPHOCYTE; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG EFFICACY; ENZYME ACTIVATION; HUMAN; MACROPHAGE; MONOCYTE; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; T LYMPHOCYTE;

ANALGESICS; ANTI-INFLAMMATORY AGENTS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CHOLINERGIC AGENTS; HUMANS;

EID: 78651264639     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-010-0243-z     Document Type: Review

References (18)

1. Goronzy JJ, Weyand CM. Developments in the scientific understanding of rheumatoid arthritis. Arthritis Res Ther. 2009;11:249.
2. Brennan FM, McInnes IB. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest. 2008;118:3537-45.
3. Fusayama T. Intratubular crystal deposition and remineralization of carious dentin. J Biol Buccale. 1991;19:255-62.
4. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000;405:458-62.
5. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 2003;421:384-8.
6. de Jonge WJ, Ulloa L. The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation. Br J Pharmacol. 2007;151:915-29.
7. Waldburger JM, Boyle DL, Pavlov VA, Tracey KJ, Firestein GS. Acetylcholine regulation of synoviocyte cytokine expression by the alpha7 nicotinic receptor. Arthritis Rheum. 2008;58:3439-49.
8. de Jonge WJ, van der Zanden EP, The FO, Bijlsma MF, van Westerloo DJ, Bennink RJ, et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol. 2005;6:844-51.
9. Walker JG, Smith MD. The Jak-STAT pathway in rheumatoid arthritis. J Rheumatol. 2005;32:1650-3.
10. van Maanen MA, Lebre MC, van der Poll T, LaRosa GJ, Elbaum D, Vervoordeldonk MJ, et al. Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. Arthritis Rheum. 2009;60:114-22.
11. Jiao R, Yang C, Zhang Y, Xu M, Yang X. Cholinergic mechanism involved in the nociceptive modulation of dentate gyrus. Biochem Biophys Res Commun. 2009;379:975-9.
12. Damaj MI, Meyer EM, Martin BR. The antinociceptive effects of alpha7 nicotinic agonists in an acute pain model. Neuropharmacology. 2000;39:2785-91.
13. Zhang P, Han D, Tang T, Zhang X, Dai K. Inhibition of the development of collagen-induced arthritis in Wistar rats through vagus nerve suspension: a 3-month observation. Inflamm Res. 2008;57:322-8.
14. Koch T, Wenzel V. Old drugs and new approval procedures: Akrinor remains marketable and an application for reapproval of Arginin Vasopressin has been made. Anaesthesist. 2006;55:708-10.
15. Laffitte E, Revuz J. Thalidomide: an old drug with new clinical applications. Expert Opin Drug Saf. 2004;3:47-56.
16. Pratt PF Jr, Wang C, Weihrauch D, Bienengraeber MW, Kersten JR, Pagel PS, et al. Cardioprotection by volatile anesthetics: new applications for old drugs? Curr Opin Anaesthesiol. 2006;19:397-403.
17. Ren W, Blasier R, Peng X, Shi T, Wooley PH, Markel D. Effect of oral erythromycin therapy in patients with aseptic loosening of joint prostheses. Bone. 2009;44:671-7.
18. Markel DC, Zhang R, Shi T, Hawkins M, Ren W. Inhibitory effects of erythromycin on wear debris-induced VEGF/Flt-1 gene production and osteolysis. Inflamm Res. 2009;58:413-21.